Vident Investment Advisory’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $331K | Buy |
|
|||||
|
2022
Q4 | $557K | Buy |
|
|||||
|
2022
Q3 | $723K | Sell |
|
|||||
|
2022
Q2 | $886K | Buy |
|
|||||
|
2022
Q1 | $862K | Buy |
|
|||||
|
2021
Q4 | $1.08M | Buy |
|
|||||
|
2021
Q3 | $977K | Sell |
|
|||||
|
2021
Q2 | $1.53M | Buy |
|
|||||
|
2021
Q1 | $1.39M | Sell |
|
|||||
|
2020
Q4 | $1.54M | Sell |
|
|||||
|
2020
Q3 | $1.67M | Sell |
|
|||||
|
2020
Q2 | $1.53M | Sell |
|
|||||
|
2020
Q1 | $1.71M | Sell |
|
|||||
|
2019
Q4 | $1.6M | Buy |
|
|||||
|
2019
Q3 | $1.25M | Sell |
|
|||||
|
2019
Q2 | $1.68M | Sell |
|
|||||
|
2019
Q1 | $1.69M | Sell |
|
|||||
|
2018
Q4 | $1.28M | Sell |
|
|||||
|
2018
Q3 | $3.17M | Sell |
|
|||||
|
2018
Q2 | $2.35M | Buy |
|